$RXST News
Last published 1w ago
- 1w agoRXSTRxSight, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoRXSTRxSight, Inc. Reports Third Quarter 2026 ResultsGlobeNewswireALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Total revenue
- 1w agoRXSTRxSight Third Quarter 2026 Earnings Conference Call - RXSIGHT INCEarnings Call TranscriptsHello, everyone. Thank you for joining us and welcome to RxSight Third Quarter 2026 Earnings Conference Call. After today's prepared remarks, we will host the question and answer session. If you would like to ask a quest
- 2w agoRXSTRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesGlobeNewswireALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456 shares of RxSight’s
- 3w agoRXSTRxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3GlobeNewswireALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on Tuesday, November 3,
- 3w agoRXSTRxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationGlobeNewswireALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice President of Sales
- 3w agoRXSTK2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the worldGlobeNewswireSeattle, WA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- K2 Vision has performed 5,000 Light Adjustable Lens (LAL) procedures. RxSight, the company that makes the lens, has recognized K2 Vision as the highest-volume LAL
- 2mo agoRXSTWELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - RXSIGHT INCEarnings Call TranscriptsHi, everyone. I am Simran Kaur. I'm one of the MedTech analysts here at Wells Fargo. I'm pleased to host RxSight for a fireside chat this morning. With us from the company are CEO Aziz Motiwala, CFO Mark Wilterding, and
- 2mo agoRXSTWELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - RXSIGHT INCEarnings Call TranscriptsHi, everyone. I am Simran Kaur. I'm one of the MedTech analysts here at Wells Fargo. I'm pleased to host RxSight for a fireside chat this morning. With us from the company are CEO Aziz Motiwala, CFO Mark Wilterding, and
- 2mo agoRXSTRxSight, Inc. to Participate in the Wells Fargo Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026,
- 3mo agoRXSTRxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 OutlookGlobeNewswireALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial outlook. Second
- 3mo agoRXSTRxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesGlobeNewswireALISO VIEJO, Calif., July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286 shares of RxSight’s
- 3mo agoRXSTRxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical OfficerGlobeNewswireALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive
- 4mo agoRXSTRXST Conference Call - RXSTEarnings Call TranscriptsHello and thank you for standing by. My name is John and I will be your conference operator today. At this time, I would like to welcome everyone to the RxSight Preliminary Second Quarter Financial Results and Product Pi
- 4mo agoRXSTRxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration AgreementGlobeNewswireALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline,
- 4mo agoRXSTALCAlcon and RxSight Announce Collaboration to Develop Adjustable PCIOLsGlobeNewswireNon-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologiesCollaboration aims to combine best-in-class PCIOL optics with first-in-class platform
- 4mo agoALCRXSTAlcon and RxSight Announce Collaboration to Develop Adjustable PCIOLsBusiness WireNon-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies Collaboration aims to combine best-in-class PCIOL optics with first-in-class
- 5mo agoRXSTRxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology ForumGlobeNewswireALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in
- 6mo agoRXST2026 GLOBAL HEALTHCARE CONFERENCERXSIGHT INCEarnings Call TranscriptsHi, everyone. I'm Stephanie El Ghazi. I cover medical devices here at Bank of America. And next up, as part of the healthcare conference, we have RxSight. We have Ron Kurtz, CEO, and Mark Wilterding, CFO. So, thank you b
- 6mo agoRXSTRxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales OutlookGlobeNewswireALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter ended March 31, 2026. Strategic Highlights and Recent Developments Q1 sales of $30.9
- 6mo agoRXSTRxSight, Inc. to Present at the Bank of America Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside
- 6mo agoRXSTRxSight, Inc. to Report First Quarter 2026 Financial Results on May 6GlobeNewswireALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The
- 7mo agoRXSTRxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026GlobeNewswireWASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over 300,000 Light
- 7mo agoRXSTRxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to
- 8mo agoRXSTRXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 GuidanceGlobeNewswireALISO VIEJO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ:RXST) today reported financial results for the quarter and full year ended December 31, 2025. Strategic Highlights and Recent Developments
- 9mo agoRXSTRxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026GlobeNewswireALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report
- 10mo agoRXSTRxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial OfficerGlobeNewswireALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 10mo agoRXSTRxSight, Inc. to Present at the J.P. Morgan Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced
- 10mo agoRXSTRxSight, Inc. Announces Chief Financial Officer TransitionGlobeNewswireALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced
- 11mo agoRXSTRxSight, Inc. to Present at the Piper Sandler Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
- 1y agoRXSTRxSight, Inc. Reports Third Quarter 2025 Financial ResultsGlobeNewswireALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 1y agoRXSTRxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025GlobeNewswireALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 1y agoRXSTRxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual MeetingGlobeNewswireALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 1y agoRXSTSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered
- 1y agoRXSTINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or the "Company")...
- 1y agoRXSTRxSight, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXSTPR NewswireThe Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the...
- 1y agoRXSTRxSight, Inc. (RXST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoRXSTINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or the "Company")...
- 1y agoRXSTThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXSTPR NewswireThe Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the...
- 1y agoRXSTSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses
- 1y agoRXSTRxSight, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RXSTPR NewswireThe Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the...
- 1y agoRXSTRxSight, Inc. to Present at the Morgan Stanley Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 1y agoRXSTSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in
- 1y agoKMTSNSPRRXSTBiobeat Technologies Names Raymond W. Cohen as Chairman of the Board of DirectorsBusiness WireBiobeat Technologies Ltd, a medical device company that has developed a wearable cuff-less ambulatory blood pressure monitoring system that records and analyzes numerous physiological parameters, today announced the
- 1y agoRXSTInvestors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXSTPR NewswireThe Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the...
- 1y agoRXSTSHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSightGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses
- 1y agoRXSTRxSight, Inc. to Present at the Wells Fargo Healthcare ConferenceGlobeNewswireALISO VIEJO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced
- 1y agoRXSTRxSight, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXSTPR NewswireThe Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the...
- 1y agoRXSTRxSight, Inc. (RXST) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoRXSTInvestors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights – RXSTGlobeNewswireNEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ:RXST). Shareholders who purchased shares of RXST during the class period listed are